Our Top Cannabis Picks For 2019

There have been many reports buzzing about the U.S. and Canadian cannabis stocks. The Canadian market has been booming since marijuana was legalized. Companies are shooting up production and distribution rates to accomplish maximum profitability. In contrast, the market in the States has become extremely cutthroat, especially with the recent signing of the 2018 Farm Bill. Those looking to invest in either the Canadian or U.S. markets are inspecting every possible factor.

Canadian Markets

The Canadian market is much more established for cannabis investors through provincial supply agreements and production capabilities through early on expansions. New companies may find it a bit more difficult to list in the Canadian market as there are no promises of secure market access for new productions. It is more likely that smaller companies will be bought out or combine with larger companies with more resources.

Investors looking into the Canadian markets should draw their attention to companies that have already attained a sturdy market position such as Canopy (CGC), Aurora (ACB), and Aphria (APHA).

Canopy Growth (CGC) is a safe option in the Canadian market. They have an impressive portfolio and investors have had a consistency plenty of growth potential.

CannTrust (otcpk: CNTTF) is another valid contender with a solid market position, significant production, and impressive Q3 earnings which are telling for approaching quarters.

Finally, OrganiGram (OGRMF) dominates the market position within eastern Canada. Next quarters revenue is estimated at $12.4 million with only the fractional presence of legalized sales.

U.S. Markets

As previously noted, the U.S. cannabis market is like the Wild West for investors. Knowing when and where to enter the market is vital to success.

The following MSO’s are believed to be lead contenders and great potential investments if you’re looking into the American market.

Cresco Labs (OTCPK: CRLBF) is fresh to the stock market yet has still held its strength post-RTO. In fact, shares are up 2.4%, however, there is still more that needs to be evaluated by the end of the month.

Harvest Health (OTC: HTHHF) has a good growth profile and high stock pricing. The next few weeks will be very telling as to if this company is as good as it seems this far.

Lastly, Acreage Holdings (OTC: ACRZF) has an experienced management team and stacked Board members. They have made almost a full recovery post-RTO.


The following information is opinion based only. We have no intentions or positions in any stocks discussed in this article. Nor do we have any business relationship with any of the previous companies. Please make investment decisions at your own discretion.


Previous Can Cannabis Treat Bad Cholesterol?